EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
EIDX
Delisted
EIDX was delisted on the 25th of January, 2021.
79 hedge funds and large institutions have $411M invested in Eidos Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 28 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
36% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 28
Holders
79
Holding in Top 10
5
Calls
$112K
Puts
–
Top Buyers
| 1 | +$7.42M | |
| 2 | +$5.99M | |
| 3 | +$5.69M | |
| 4 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$5.11M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$4.54M |
Top Sellers
| 1 | -$27.4M | |
| 2 | -$3.74M | |
| 3 | -$3.42M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.92M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$1.85M |